14MG

Genomill Health

Genomill Health develops targeted sequencing technology for liquid biopsies to assist clinical laboratories and pharmaceutical companies with precision cancer diagnostics.

D2G Oncology

This company develops genomic drug screening platforms and mouse models to identify genotype-specific cancer treatments for healthcare institutions and pharmaceutical researchers.

DNA1

This company develops a platform for relating phenotype to genotype to accelerate discoveries in diagnostics, precision medicine, and genetics for healthcare organisations.

Predicta Biosciences

This company develops blood-based genomic diagnostic tests for clinicians and pharmaceutical partners to monitor and treat blood cancers.

Enumera Molecular

The company develops genomic analysis platforms and workflows for clinical laboratories to perform rapid and cost-effective liquid biopsy and diagnostic testing.

Findmecure

This company provides a search platform for clinical trials to help patients discover and understand medical treatments currently in development.

Coral Genomics

This biotechnology platform provides genomic data and drug response models to help medical professionals and pharmaceutical companies optimize drug development and personalised medicine.

Imagenomix

The company develops an artificial intelligence platform that predicts cancer mutations from pathology images for healthcare providers and biopharma companies.